DE2619715A1 - Tumor-antigen und verfahren zu dessen herstellung - Google Patents

Tumor-antigen und verfahren zu dessen herstellung

Info

Publication number
DE2619715A1
DE2619715A1 DE19762619715 DE2619715A DE2619715A1 DE 2619715 A1 DE2619715 A1 DE 2619715A1 DE 19762619715 DE19762619715 DE 19762619715 DE 2619715 A DE2619715 A DE 2619715A DE 2619715 A1 DE2619715 A1 DE 2619715A1
Authority
DE
Germany
Prior art keywords
tumor
chain
lysolecithin
long
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19762619715
Other languages
German (de)
English (en)
Inventor
Manuel Dr Modolell
Paul Gerhard Dr Munder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority to DE19762619715 priority Critical patent/DE2619715A1/de
Priority to NL7704724A priority patent/NL7704724A/xx
Priority to NZ183980A priority patent/NZ183980A/xx
Priority to IL51989A priority patent/IL51989A/xx
Priority to SE7705070A priority patent/SE7705070L/xx
Priority to IT23093/77A priority patent/IT1074325B/it
Priority to GB18430/77A priority patent/GB1575545A/en
Priority to AU24818/77A priority patent/AU517395B2/en
Priority to DK194477A priority patent/DK194477A/da
Priority to LU77245A priority patent/LU77245A1/xx
Priority to AT313277A priority patent/AT362497B/de
Priority to CA277,457A priority patent/CA1077840A/en
Priority to IE887/77A priority patent/IE44943B1/en
Priority to FR7713521A priority patent/FR2391733A1/fr
Priority to BE177279A priority patent/BE854269A/xx
Priority to JP5194377A priority patent/JPS52134011A/ja
Priority to ZA00772648A priority patent/ZA772648B/xx
Publication of DE2619715A1 publication Critical patent/DE2619715A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19762619715 1976-05-04 1976-05-04 Tumor-antigen und verfahren zu dessen herstellung Withdrawn DE2619715A1 (de)

Priority Applications (17)

Application Number Priority Date Filing Date Title
DE19762619715 DE2619715A1 (de) 1976-05-04 1976-05-04 Tumor-antigen und verfahren zu dessen herstellung
NL7704724A NL7704724A (nl) 1976-05-04 1977-04-29 Tumor-antigeen en zijn bereiding.
NZ183980A NZ183980A (en) 1976-05-04 1977-05-02 Preparation of tumour antigens from tumour cells immunotherapeutic medicament
IL51989A IL51989A (en) 1976-05-04 1977-05-02 Process for preparing tumor antigens by treating tumor cells with lysolecithin analogs
SE7705070A SE7705070L (sv) 1976-05-04 1977-05-02 Tumor-antigen och forfarande for dess framstellning
IT23093/77A IT1074325B (it) 1976-05-04 1977-05-02 Antigene tumorale e processo per la sua preparazione
GB18430/77A GB1575545A (en) 1976-05-04 1977-05-03 Tumour antigen and process for the preparation thereof
AU24818/77A AU517395B2 (en) 1976-05-04 1977-05-03 Tumor antigen
DK194477A DK194477A (da) 1976-05-04 1977-05-03 Tumor-antigen dets fremstilling og anvendelse
LU77245A LU77245A1 (enExample) 1976-05-04 1977-05-03
AT313277A AT362497B (de) 1976-05-04 1977-05-03 Verfahren zur herstellung von tumor-antigenen
CA277,457A CA1077840A (en) 1976-05-04 1977-05-03 Tumor antigen and process for the preparation thereof
IE887/77A IE44943B1 (en) 1976-05-04 1977-05-03 Tumor antigen and process for the preparation thereof
FR7713521A FR2391733A1 (fr) 1976-05-04 1977-05-04 Antigene contre les tumeurs et son procede de preparation
BE177279A BE854269A (fr) 1976-05-04 1977-05-04 Antigene contre les tumeurs et son procede de preparation
JP5194377A JPS52134011A (en) 1976-05-04 1977-05-04 Production of tumor antigen
ZA00772648A ZA772648B (en) 1976-05-04 1977-05-05 Tumor antigen and process for the preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762619715 DE2619715A1 (de) 1976-05-04 1976-05-04 Tumor-antigen und verfahren zu dessen herstellung

Publications (1)

Publication Number Publication Date
DE2619715A1 true DE2619715A1 (de) 1977-11-24

Family

ID=5977057

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762619715 Withdrawn DE2619715A1 (de) 1976-05-04 1976-05-04 Tumor-antigen und verfahren zu dessen herstellung

Country Status (17)

Country Link
JP (1) JPS52134011A (enExample)
AT (1) AT362497B (enExample)
AU (1) AU517395B2 (enExample)
BE (1) BE854269A (enExample)
CA (1) CA1077840A (enExample)
DE (1) DE2619715A1 (enExample)
DK (1) DK194477A (enExample)
FR (1) FR2391733A1 (enExample)
GB (1) GB1575545A (enExample)
IE (1) IE44943B1 (enExample)
IL (1) IL51989A (enExample)
IT (1) IT1074325B (enExample)
LU (1) LU77245A1 (enExample)
NL (1) NL7704724A (enExample)
NZ (1) NZ183980A (enExample)
SE (1) SE7705070L (enExample)
ZA (1) ZA772648B (enExample)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040039A1 (en) * 1980-05-08 1981-11-18 Takeda Chemical Industries, Ltd. Ethylene glycol derivatives of ammonioethyl phosphate, their production and use
EP0050327A1 (de) * 1980-10-21 1982-04-28 Roche Diagnostics GmbH Neue schwefelhaltige Phospholipide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0050460A3 (en) * 1980-10-22 1982-10-27 Takeda Chemical Industries, Ltd. Tridecyloxy- or tetradecyloxy-propane derivatives, and their use
EP0102801A3 (en) * 1982-08-20 1985-01-16 Koken Ltd. An agent for inhibiting proliferation of malignant tumour cells
US4562179A (en) * 1982-04-19 1985-12-31 Fujisawa Pharmaceutical Co., Ltd. Phospholipid derivatives, and pharmaceutical composition of the same
US4888328A (en) * 1988-03-10 1989-12-19 Hoeschst-Roussel Incorporated Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids
EP0395849A1 (de) * 1989-03-04 1990-11-07 Roche Diagnostics GmbH /3-(C16-C18)alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl/-(2-trimethylammonio-ethyl)phosphate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US5030733A (en) * 1987-07-23 1991-07-09 Hoechst-Roussel Pharmaceticals Incorporated Hydroxy-, alkoxy- and benzyloxy-substituted phospholipids
US5036152A (en) * 1988-03-10 1991-07-30 Hoechst-Roussel Pharmaceuticals Incorporated Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids
US5145844A (en) * 1987-07-23 1992-09-08 Hoechst-Roussel Pharmaceuticals Incorporated Methods of using hydroxy-, alkoxy- and benzyloxy-substituted phospholipids to treat phospholipase A2 -mediated conditions and to alleviate pain

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58138383A (ja) * 1982-02-13 1983-08-17 Nippon Shinyaku Co Ltd 生理活性物質の製法
JPS6081194A (ja) * 1983-10-11 1985-05-09 Takeda Chem Ind Ltd ケトアルキルリン脂質
JP2561478B2 (ja) * 1986-07-22 1996-12-11 武田薬品工業株式会社 グリセリン誘導体

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040039A1 (en) * 1980-05-08 1981-11-18 Takeda Chemical Industries, Ltd. Ethylene glycol derivatives of ammonioethyl phosphate, their production and use
EP0050327A1 (de) * 1980-10-21 1982-04-28 Roche Diagnostics GmbH Neue schwefelhaltige Phospholipide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0050460A3 (en) * 1980-10-22 1982-10-27 Takeda Chemical Industries, Ltd. Tridecyloxy- or tetradecyloxy-propane derivatives, and their use
US4544512A (en) * 1980-10-22 1985-10-01 Takeda Chemical Industries, Ltd. Tridecyloxy- or tetradecyloxy-propane derivatives
US4562179A (en) * 1982-04-19 1985-12-31 Fujisawa Pharmaceutical Co., Ltd. Phospholipid derivatives, and pharmaceutical composition of the same
EP0102801A3 (en) * 1982-08-20 1985-01-16 Koken Ltd. An agent for inhibiting proliferation of malignant tumour cells
US5030733A (en) * 1987-07-23 1991-07-09 Hoechst-Roussel Pharmaceticals Incorporated Hydroxy-, alkoxy- and benzyloxy-substituted phospholipids
US5145844A (en) * 1987-07-23 1992-09-08 Hoechst-Roussel Pharmaceuticals Incorporated Methods of using hydroxy-, alkoxy- and benzyloxy-substituted phospholipids to treat phospholipase A2 -mediated conditions and to alleviate pain
US4888328A (en) * 1988-03-10 1989-12-19 Hoeschst-Roussel Incorporated Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids
US5036152A (en) * 1988-03-10 1991-07-30 Hoechst-Roussel Pharmaceuticals Incorporated Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids
EP0395849A1 (de) * 1989-03-04 1990-11-07 Roche Diagnostics GmbH /3-(C16-C18)alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl/-(2-trimethylammonio-ethyl)phosphate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US5543402A (en) * 1989-03-04 1996-08-06 Boehringer Mannheim Gmbh [3-(C16 -C18)-alkanesulphinyl and sulphonyl-2-methoxy-methylpropyl]-(2-trimethylammonioethyl) phosphates, processes for the preparation thereof and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AU517395B2 (en) 1981-07-30
IL51989A0 (en) 1977-07-31
CA1077840A (en) 1980-05-20
NZ183980A (en) 1980-04-28
NL7704724A (nl) 1977-11-08
JPS52134011A (en) 1977-11-09
AU2481877A (en) 1978-11-09
FR2391733B1 (enExample) 1980-03-07
SE7705070L (sv) 1977-11-05
DK194477A (da) 1977-11-05
IE44943L (en) 1977-11-04
IT1074325B (it) 1985-04-20
GB1575545A (en) 1980-09-24
LU77245A1 (enExample) 1977-12-13
BE854269A (fr) 1977-11-04
FR2391733A1 (fr) 1978-12-22
IL51989A (en) 1980-01-31
ATA313277A (de) 1980-10-15
IE44943B1 (en) 1982-05-19
ZA772648B (en) 1978-04-26
AT362497B (de) 1981-05-25

Similar Documents

Publication Publication Date Title
DE3833319C2 (enExample)
DE3227262C2 (enExample)
DE3008082A1 (de) Carcinostatisches und die immunreaktion stimulierendes mittel, enthaltend lysophospholipid und phospholipid, und verfahren zur herstellung desselben
DE2619715A1 (de) Tumor-antigen und verfahren zu dessen herstellung
DE2638762A1 (de) Wasserloesliche adjuvantien, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE3149360A1 (de) "verfahren zur reinigung und/oder phytohaemagglutinin-abtrennung von human-interleukin-2"
DE2519938A1 (de) Extrakte von corynebakterien, verfahren zu ihrer herstellung und ihre verwendung in arzneimittelzubereitungen
DE2735411A1 (de) Verfahren zur herstellung von acellulaeren vaccinen und nach diesem verfahren gewonnene vaccine
EP0222974B1 (de) Verfahren zur Herstellung eines Tollwutimpfstoffes und nach diesem Verfahren erhaltener Impfstoff
DE2323981B2 (de) Verfahren zur Isolierung des thrombinartig wirkenden Bestandteils aus dem Gift der Otter Agkistrodon rhodostoma
EP0145005A2 (de) Lungen-Surfactant, Verfahren zu seiner Herstellung und seine pharmazeutische Verwendung
DE2518474A1 (de) Mitogenes mittel, verfahren zu seiner herstellung und diese mittel enthaltende arzneimittel und biologische reagenzien
DE2457047B2 (de) Verfahren zur Herstellung eines Derivates der leichten Kette des Tetanustoxins, dessen Verwendung zur Tetanusprophylaxe
CH404858A (de) Verfahren zur Herstellung von wachstumfördernde Stoffe enthaltenden Präparaten
DE1617332C3 (de) Verfahren zum Isolieren eines wasserlöslichen Protein-Metall-Chelats mit antiphlogistischer Wirkung
CH650154A5 (de) Wasserloesliche, biologisch aktive fraktion aus dem interzellularen medium des knochenmarks, verfahren zu deren gewinnung und diese enthaltende pharmazeutische zubereitung.
DE3032606C2 (de) Polysaccharidderivat der Streptokinase, Verfahren zu dessen Herstellung und Anwendung
DE69526096T2 (de) Wachstumsregulator
DE1293705B (de) Verfahren zur Gewinnung eines elastolytisch wirksamen Bauchspeicheldruesen-Praeparates
DE69026275T2 (de) Verfahren zur herstellung von ribonuklease-dimeren
DE1802386C2 (de) Verfahren zur Gewinnung von cytobiotischen Globulinen
DE3114641A1 (de) Immunosuppresives mittel in einer dosierungseinheit und verfahren zu seiner herstellung
DE2335334A1 (de) Verfahren zur herstellung von hochgereinigten phosphatiden aus tierischen organen
DE3323094C2 (enExample)
DE2714443C3 (de) Hersteilung einer parenteral zu applizierenden Lösung für die Behandlung von Krebs und schwer heilbaren Hauterkrankungen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8181 Inventor (new situation)

Free format text: MUNDER, PAUL GERHARD, DR., 7830 EMMENDINGEN, DE MODOLELL, MANUEL, DR., 7801 VOERSTETTEN, DE

8139 Disposal/non-payment of the annual fee